Home Care's AI Awakening: Stealth Startup Lands $6M to Bring Responsible Intelligence to an Overlooked Healthcare Sector
Tempus AI Reports 75% Revenue Growth in Q1 2026, Driven by Genomics and Data Licensing
Tempus AI has reported first-quarter 2026 revenue of $255 million, a 75% increase year-over-year, driven by strong growth in its genomics testing and data licensing segments as the company continues its post-IPO expansion.
Aidoc Raises $150 Million Series E Led by Goldman Sachs to Scale Clinical Foundation Model
Aidoc has closed a $150 million Series E round led by Goldman Sachs, with participation from existing investors, to scale its CARE clinical AI foundation model and expand its presence in radiology and emergency medicine workflows globally.
Innovaccer Acquires CaduceusHealth to Build Autonomous Revenue Cycle Management
Innovaccer has acquired CaduceusHealth for $66 million, combining its health data platform with CaduceusHealth's autonomous revenue cycle management capabilities to address the $265 billion annual cost of claim denials in U.S. healthcare.
Roche Acquires PathAI for $750 Million to Transform AI-Driven Pathology
Roche has agreed to acquire PathAI, the Boston-based digital pathology AI company, for approximately $750 million. The deal combines Roche's global diagnostics infrastructure with PathAI's FDA-cleared AI models for tissue analysis and biomarker identification.
Spring Health Raises $100 Million Series E to Expand AI-Matched Mental Health Benefits
Spring Health has closed a $100 million Series E funding round to expand its AI-powered mental health benefits platform, which uses machine learning to match employees with personalized care pathways and has reduced average time-to-first-appointment from 25 days to 2 days.